Overview
A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone
Status:
Completed
Completed
Trial end date:
2015-01-01
2015-01-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The purpose of this study is to compare the pharmacokinetics of DP-R207 (Rosuvastatin 10mg and Ezetimibe 10mg fixed dose combinations) in comparison to each component administered alone in health male volunteers.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Alvogen KoreaTreatments:
Ezetimibe
Rosuvastatin Calcium
Criteria
Inclusion Criteria:- Healthy male subjects age between 19 and 55 signed informed consent
Exclusion Criteria:
- subjects have an allergy reaction of this drug